📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections. (2022)

First Author: Zhu J

Attributed to: CALOPUS - Computer Assisted LOw-cost Point-of-care UltraSound funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-3-030-32692-0_21

PubMed Identifier: 36407474

Publication URI: http://europepmc.org/abstract/MED/36407474

Type: Journal Article/Review

Volume: 2

Parent Publication: Intensive care research

Issue: 3-4

ISSN: 2666-9862